Merck
MRK
$105.06
Share price
1.55%
Change (1 day)
-4.50%
Change (1 year)
Categories
Revenue for Merck (MRK)
Revenue in 2023 (TTM): $59.31 B
According to Merck's latest financial reports the company's current revenue (TTM) is $59.31 B. In 2022 the company made a revenue of $59.28 B an increase over the years 2021 revenue that were of $50.15 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Merck from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $59.31 B | 0.05% |
| 2022 | $59.28 B | 18.19% |
| 2021 | $50.15 B | 4.51% |
| 2020 | $47.99 B | 2.46% |
| 2019 | $46.84 B | 10.75% |
| 2018 | $42.29 B | 5.41% |
| 2017 | $40.12 B | 0.79% |
| 2016 | $39.80 B | 0.78% |
| 2015 | $39.49 B | -6.48% |
| 2014 | $42.23 B | -4.08% |
| 2013 | $44.03 B | -6.18% |
| 2012 | $46.93 B | -2.32% |
| 2011 | $48.04 B | 4.48% |
| 2010 | $45.98 B | 67.66% |
| 2009 | $27.42 B | 15% |
| 2008 | $23.85 B | -1.44% |
| 2007 | $24.19 B | 6.9% |
| 2006 | $22.63 B | 2.84% |
| 2005 | $22.01 B | -4.04% |
| 2004 | $22.93 B | -39.73% |
| 2003 | $38.05 B | -26.51% |
| 2002 | $51.79 B | 8.54% |
| 2001 | $47.71 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $91.32 B | 53.96% | 🇺🇸 USA |
 Novartis NVS | $52.32 B | -11.79% | 🇨🇭 Switzerland |
 Pfizer PFE | $68.53 B | 15.55% | 🇺🇸 USA |
 Abbott Laboratories ABT | $39.95 B | -32.63% | 🇺🇸 USA |
 Eli Lilly LLY | $32.07 B | -45.93% | 🇺🇸 USA |
 Amgen AMGN | $26.83 B | -54.76% | 🇺🇸 USA |
 Sanofi SNY | $49.13 B | -17.15% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $44.93 B | -24.24% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $36.53 B | -38.40% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $15.27 B | -74.25% | 🇮🇱 Israel |